Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling
Daniela Egli-Spichtig(University of California, San Francisco), Farzana Perwad(University of California, San Francisco)
Cited by 1
Related Papers
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
|The Lancet|2019|375
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease
|Kidney International|2014|94